NCI awards Metabolomx SBIR contract to develop sensor array system for detecting lung

[News]

Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.

More... (http://www.news-medical.net/news/20111024/NCI-awards-Metabolomx-SBIR-contract-to-develop-sensor-array-system-for-detecting-lung-cancer.aspx)